About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
R
POEMS Syndrome Management
By
MyCancerHaven
FEATURING
Ravi Vij
,
David Dingli
By
MyCancerHaven
FEATURING
Ravi Vij
,
David Dingli
397 views
May 7, 2024
0 Comments
Login to view comments.
Click here to Login
Featured Video
07:44
Incyte
Optimizing the Management of Patients with Polycythemia Vera (PV)
Feat.
P. Bose,
R. Rampal
Featured Video
16:51
Incyte
Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk
Feat.
C. Harrison
Related Content
AUTOPLAY
ON
21:05
Louisville Hematology Highlights
Why Are Our Hematopoietic Stem Cells in the Bone Marrow?
Feat.
R. Gale
17:52
Indy Hematology Review
2024 Updates on Emerging & Current Treatment of Multiple Myeloma
Feat.
K. Anderson
20:17
Indy Hematology Review
Managing Amyloidosis in 2024: Diagnosis and Treatment
Feat.
M. Gertz
16:42
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "The Best of Myeloma - Highlights & Key T…
Feat.
H. Hashmi
24:35
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "The Best of Myeloma - Review of the Top 5 …
Feat.
H. Hashmi
35:27
Dana-Farber Cancer Institute
Advances in Multiple Myeloma 2024: From Bench to Bedside
Feat.
K. Anderson
17:46
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Highlights in 1L MM - Quadruplet Therapies …
Feat.
A. Jakubowiak
24:23
MyCancerHaven
Will CAR-Ts and Bispecifics Replace HSCT in Myeloma?
Feat.
R. Vij,
S. Al Hadidi
28:20
Indy Hematology Review
Managing Newly Diagnosed MM in 2024
Feat.
S. Usmani
20:23
SOHO Brazil 2024
When to Consider Bispecific and CAR-T Therapy in MM
Feat.
N. S. Raje
15:46
Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course
Overview of Monoclonal Gammopathies From MGUS to Smoldering Myeloma
Feat.
M. Kwok
24:44
Indy Hematology Review
State of the Art in 2024: Emerging Therapies in Hematologic Malignan…
Feat.
R. Birhiray
09:51
i3 Health
MRD Testing in Leukemias: When Negativity Is a Positive Thing
Feat.
N. S. Raje
15:35
Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course
Multiple Myeloma: Not as Simple as "CRAB" Anymore
Feat.
R. Banerjee
19:08
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "Practice Changing Updates in MM, SMM and MGU…
Feat.
R. Banerjee
36:10
Insights from 2024 EHA Annual Meeting
Highlights in Plasma Cell Disorders From ASCO® and EHA
Feat.
S. Al Hadidi
13:15
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Quadruplets in NDMM - The More the Better?…
Feat.
O. Landgren
13:47
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "MRD2STOP Study - Discontinuation of Maint…
Feat.
B. Derman
19:24
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Updates on Managing Newly Diagnosed MM - In…
Feat.
P. Richardson
22:33
Integrity CE
Treatment Strategies for R/R MM After Frontline Anti-CD38 Therapy
Feat.
S. Usmani,
J. Hillengass